Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancer

被引：4
|
作者：
Tombal, Bertrand
Borre, Michael
Rathenborg, Per
Werbrouck, Patrick
Heidenreich, Axel
Iversen, Peter
Baskin-Bey, Edwina S.
Perabo, Frank
Phung, De
Smith, Matthew Raymond
机构：
[1] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium
[2] Arhus Univ Hosp, Dept Urol, Skejby, Denmark
[3] Herlev Hosp, DK-2730 Herlev, Denmark
[4] AZ Groeninge Kortrijk, Kortrijk, Belgium
[5] Klin & Poliklin Urol, North Rhine Westphalia, Germany
[6] Univ Copenhagen, Rigshosp, DK-2100 Copenhagen, Denmark
[7] Astellas Pharma Europe Ltd, Staines, England
[8] Astellas Pharma Inc, Leiderdorp, Netherlands
[9] Astellas Pharma Europe BV, Leiderdorp, Netherlands
[10] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naive men with oligometastatic prostate cancer to bone.
    Tward, Jonathan David
    Johnson, Skyler B.
    Kokeny, Kristine E.
    Lloyd, Shane
    Cannon, Donald Maurice
    Dechet, Christopher B.
    ONeil, Brock
    Stephenson, Robert
    Boucher, Kenneth M.
    Gupta, Sumati
    Swami, Umang
    Maughan, Benjamin L.
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [42] Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study
    Beer, Tomasz M.
    Armstrong, Andrew J.
    Sternberg, Cora N.
    Higano, Celestia S.
    Iversen, Peter
    Loriot, Yohann
    Rathkopf, Dana E.
    Bhattacharya, Suman
    Carles, Joan
    De Bono, Johann S.
    Evans, Christopher P.
    Joshua, Anthony M.
    Kim, Choung-Soo
    Kimura, Go
    Mainwaring, Paul N.
    Mansbach, Harry H.
    Miller, Kurt
    Noonberg, Sarah B.
    Venner, Peter M.
    Tombal, Bertrand
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [43] Enzalutamide in Men With Chemotherapy- Naive Metastatic Prostate Cancer (mCRPC): Results of Phase III PREVAIL Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (04) : 3 - 4
  • [44] Impact of nutritional status on the prognosis of patients with metastatic hormone-naive prostate cancer: a multicenter retrospective cohort study in Japan
    Okamoto, Teppei
    Hatakeyama, Shingo
    Narita, Shintaro
    Takahashi, Masahiro
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishida, Masanori
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Shimoda, Jiro
    Sato, Hiromi
    Mitsuzuka, Koji
    Tochigi, Tatsuo
    Tsuchiya, Norihiko
    Arai, Yoichi
    Habuchi, Tomonori
    Ohyama, Chikara
    WORLD JOURNAL OF UROLOGY, 2019, 37 (09) : 1827 - 1835
  • [45] The Needle in the Haystack: The Presence of Castrate-resistant Prostate Cancer Cells in Hormone-naive Prostate Cancer
    Ali, Amin
    Baena, Esther
    EUROPEAN UROLOGY, 2022, 81 (05) : 456 - 457
  • [46] Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naive Prostate Cancer: 3-Year Open Label Followup Results
    Tombal, Bertrand
    Borre, Michael
    Rathenborg, Per
    Werbrouck, Patrick
    Van Poppel, Hendrik
    Heidenreich, Axel
    Iversen, Peter
    Braeckman, Johan
    Heracek, Jiri
    Baron, Benoit
    Krivoshik, Andrew
    Section, Mohammad Hirmand
    Smith, Matthew R.
    JOURNAL OF UROLOGY, 2018, 199 (02): : 459 - 464
  • [47] TP53 alterations of hormone-naive prostate cancer in the Chinese population
    Liu, Zhengfang
    Guo, Hu
    Zhu, Yaofeng
    Xia, Yangyang
    Cui, Jianfeng
    Shi, Kai
    Fan, Yidong
    Shi, Benkang
    Chen, Shouzhen
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (02) : 482 - 491
  • [48] Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
    Merson, S.
    Yang, Z. H.
    Brewer, D.
    Olmos, D.
    Eichholz, A.
    McCarthy, F.
    Fisher, G.
    Kovacs, G.
    Berney, D. M.
    Foster, C. S.
    Moller, H.
    Scardino, P.
    Cuzick, J.
    Cooper, C. S.
    Clark, J. P.
    BRITISH JOURNAL OF CANCER, 2014, 110 (06) : 1655 - 1662
  • [49] Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
    S Merson
    Z H Yang
    D Brewer
    D Olmos
    A Eichholz
    F McCarthy
    G Fisher
    G Kovacs
    D M Berney
    C S Foster
    H Møller
    P Scardino
    J Cuzick
    C S Cooper
    J P Clark
    British Journal of Cancer, 2014, 110 : 1655 - 1662
  • [50] The impact of time-to-castration resistance on survival in patients with metastatic hormone-naive prostate cancer: A multicenter retrospective study
    Okamoto, Teppei
    Hatakeyama, Shingo
    Takahashi, Masahiro
    Narita, Shintaro
    Ishida, Masanori
    Hoshi, Senji
    Kawamura, Sadafumi
    Ishidoya, Shigeto
    Shimoda, Jiro
    Kawaguchi, Toshiaki
    Tochigi, Tatsuo
    Mitsuzuka, Koji
    Tsuchiya, Norihiko
    Arai, Yoichi
    Habuchi, Tomonori
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345